Approximately half of the cases of triple-negative breast cancer and inflammatory breast cancer overexpress EGFR, but MCF7 cells, a model of hormone-positive breast cancer, are characterized as EGFRlow cells [29]. This evidence concerns the gene EGFR and inflammatory breast carcinoma.